Literature DB >> 11324978

Ocular complications of latanoprost in uveitic glaucoma: three case reports.

S Saccà1, A Pascotto, C Siniscalchi, M Rolando.   

Abstract

The purpose of this study was to report paradoxical reaction on the intraocular pressure after treatment with latanoprost in 3 cases of uveitic glaucoma. Serial clinical examinations of intraocular pressure by means of daily tonometric curves were performed in three patients with uveitic glaucoma before and after the beginning of latanoprost therapy. All measurements were performed by two doctors, but every patient's IOP was always measured by the same doctor. Adverse reactions, such as increased intraocular pressure and recurrence of inflammation, were noted to occur 7 to 16 days after rechallenging with topical latanoprost therapy for glaucoma in patients with history of uveitic glaucoma. The conclusion indicates that clinicians should be alerted to these possible complications of topical latanoprost therapy in uveitic glaucoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11324978     DOI: 10.1089/10807680151125393

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  9 in total

Review 1.  Paradoxical and bidirectional drug effects.

Authors:  Silas W Smith; Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Uveitis-induced Refractory Ocular Hypotony Managed with High-dose Latanoprost.

Authors:  Fariba Ghassemi; Mohammad Reza Niyousha; Narges Hassanpoor; Hassan Khojasteh
Journal:  J Ophthalmic Vis Res       Date:  2020-08-06

3.  Efficacy and safety of latanoprost in eyes with uveitic glaucoma.

Authors:  Nikos N Markomichelakis; Agori Kostakou; Ioannis Halkiadakis; Sonia Chalkidou; Dimitrios Papakonstantinou; Gerasimos Georgopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-28       Impact factor: 3.117

4.  First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2007-09

Review 5.  [Intraocular pressure related to uveitis].

Authors:  U Pleyer; P Ruokonen; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

Review 6.  [Glaucoma and uveitis. Causes of and treatment options for increased intraocular pressure in cases of inflammatory ophthalmology].

Authors:  T S Dietlein
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

Review 7.  Latanoprost : an update of its use in glaucoma and ocular hypertension.

Authors:  Caroline M Perry; Jane K McGavin; Christine R Culy; Tim Ibbotson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma.

Authors:  Simon Rj Taylor; Avinash Gurbaxani; Ahmed Sallam; Sue Lightman
Journal:  Open Ophthalmol J       Date:  2012-08-24

Review 9.  Current Approach in the Diagnosis and Management of Uveitic Glaucoma.

Authors:  Francisco J Muñoz-Negrete; Javier Moreno-Montañés; Paula Hernández-Martínez; Gema Rebolleda
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.